Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Y4HR
|
|||
Drug Name |
PMID25991433-Compound-E3
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
F. HOFFMANN-LA ROCHE AG
|
|||
Structure |
Download2D MOL |
|||
Formula |
C32H23ClN4O4
|
|||
Canonical SMILES |
C1=CC=C(C=C1)CN2C=CC(=CC2=O)C(=O)NCC3=C(N(C4=C(C3=O)C=CC(=C4)Cl)C5=CC=CC=C5)C6=NC=CO6
|
|||
InChI |
1S/C32H23ClN4O4/c33-23-11-12-25-27(18-23)37(24-9-5-2-6-10-24)29(32-34-14-16-41-32)26(30(25)39)19-35-31(40)22-13-15-36(28(38)17-22)20-21-7-3-1-4-8-21/h1-18H,19-20H2,(H,35,40)
|
|||
InChIKey |
CDEQUNLOBIAUNN-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).Expert Opin Ther Pat. 2015;25(8):849-72. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.